ReviewCurrent atherosclerosis reports2022

ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.

Farzahna Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.